Advancing Cancer Research
& Treatment for Patients
Around the Globe.
Upcoming CR&T Events
Registration is now open: CR&T's 13th International Patient Symposium on Myeloproliferative Neoplasms (MPNs)
Cancer Research & Treatment Fund (CR&T) is proud to host the 13th International Patient Symposium for individuals with myeloproliferative neoplasms (MPNs), their families, and friends on Wednesday, October 23, 2024, at the Belfer Research Building, Weill Cornell Medicine.
Patients and guests attending this day-long symposium will learn about the latest research developments and treatment practices from distinguished MPN researchers and physicians. This is a unique opportunity to engage with guest speakers from the most prestigious cancer centers in the world.
More information is available on the MPN Symposium tab.
About the CR&T
Who We Are
In 1968, Richard T. Silver, MD, a prominent hematologist-oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer. While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 56-year history, CR&T has awarded more than $17 million in grants to research that has contributed to major advances in the fight against cancer.
BLOOD CANCER
RESEARCH
THE DR. RICHARD
T. SILVER CHAIR
FOR OTHER
CANCER RESEARCH
CR&T Gallery
Medical Advisory Board
At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.
Your gift today can help change a cancer patient's life.
More Ways to Give